Second COVID-19 trial paused within 24 hours over safety concerns

(Agence France-Presse) - October 14, 2020 - 1:21pm WASHINGTON, United States — Two late-stage COVID-19 medical trials have been paused in the space of 24 hours over potential safety concerns, the latest setbacks to scientists in the long fight against the pandemic. US pharmaceutical firm Eli Lilly on Tuesday suspended its Phase 3 trial of its lab-produced antibody treatment in hospitalized patients over an unspecified incident. A day earlier, the American pharmaceutical giant Johnson & Johnson temporarily halted its Phase 3 COVID-19 vaccine trial due to an unexplained illness in a study participant. J&J's research head Mathai Mammen told investors Tuesday it was a "temporary pause" that could be unrelated to their drug. It's not unusual for final stage clinical trials to hit a problem -- indeed, they are designed to scale up the number of participants to thousands or tens of thousands to tease out side effects that may be very rare. Last month, British firm AstraZeneca became the first in the world to announce a pause of its vaccine trials after one patient in Britain was diagnosed with an inflammatory condition affecting the spine. The trial was later resumed around the world but remains suspended in the US for reasons that are unclear. Doctor and scientist Eric Topol, who directs the Scripps Research Institute, tweeted that he was surprised to hear about the safety concern with Lilly's antibody treatment, because earlier stages didn't reveal any serious side effects. "Hopefully a brief pause and we'll get details quickly. Good to be cautious," he said. Trump treatment "Lilly is supportive of the decision by the independent DSMB (data safety monitoring board) to cautiously ensure the safety of the patients participating in this study," a spokesperson told AFP in a statement Tuesday. The study began in August across more than 50 sites in the United States, Denmark and Singapore with the aim of recruiting 10,000 people. Lab-produced antibody treatments have been making headlines recently after US President Donald Trump credited one therapy, developed by biotech firm Regeneron, with curing him of COVID-19. Both Lilly and Regeneron last week applied to the US Food and Drug Administration for emergency use authorizations for their treatments. Monoclonal antibodies are a relatively new class of drugs that are best known for treating certain types of cancer and autoimmune disease. Human immune systems produce antibodies, which are infection-fighting proteins, and vaccines teach our bodies to be prepared to make the right ones for particular pathogens. The COVID-19 treatment studied in the paused trial was based on an effective antibody Lilly found in a recovered patient. The host immune cells that produce the antibodies can be cultured in a lab to produce the desired proteins en masse. Lilly didn't disclose any details about the safety concern or how many people are affected. But generally speaking, mild side effects of intravenously administered therapies can include fevers, chills and fatigue, while moderate to severe infusions can cause chest pain and shortness of breath. J&J seeks to reassure J&J, meanwhile, moved to buoy confidence in its vaccine. "It's not at all unusual for unexpected illnesses (to occur) in large studies over their duration," Mammen said in a conference call. "In some cases, serious adverse events... may have something or nothing to do with the drug or vaccine being investigated," he said. The final stage of J&J's trial had started recruiting participants in late September, with a goal of enrolling volunteers across more than 200 US and international locations. J&J is one of 11 organizations globally to begin a Phase 3 trial on a COVID-19 vaccine. Washington has given the multinational about $1.45 billion in funding under Operation Warp Speed. The vaccine is based on a single dose of a cold-causing adenovirus, modified so that it can no longer replicate, combined with a part of the new coronavirus called the spike protein that it uses to invade human cells. J&J used the same technology in its Ebola vaccine, which received marketing approval from the European Commission in July. At close of trading, J&J was down 2.3% while Lilly was down 2.9%.

Comments

Post a Comment

Popular posts from this blog

PCG: China’s bullying in West Philippine Sea undermines international law --- Ghio Ong - The Philippine Star

MANILA, Philippines — Letting China sustain its aggression in the West Philippine Sea would make other countries doubt the strength of international law currently being asserted by the Philippines, Commodore Jay Tarriela of the Philippine Coast Guard (PCG) said. “Allowing China to blatantly disregard the established rules-based order threatens the very foundation that we all depend on,” he wrote in a post on X last Tuesday. He added, “If we permit this, countries worldwide may forget why this order was created in the first place. Nations could begin to doubt the significance of adhering to international law if powerful bullies can easily violate it.” Tarriela also said defiance of other countries to a rules-based order would result in the prevalence of cruelty. He wrote, “This could lead us back to a time when might makes right, undermining the global structures that keep human greed, savagery and barbarism in check. Such a scenario would not only invite challenges from aggressive ...
Read more

China ships maintain presence in key West Philippine Sea areas --- Michael Punongbayan - The Philippine Star

STAR / Michael Varcas MANILA, Philippines — While Chinese vessels in the West Philippine Sea (WPS) have decreased in number, they have maintained a presence in three key land features where naval and coast guard ships have intensified operations in the past seven days, according to the Philippine Navy. Latest monitoring by the Philippine Navy showed armed ships of the People’s Liberation Army Navy (PLAN) maintaining a menacing presence around the grounded BRP Sierra Madre in Ayungin Shoal, Panatag Shoal and Escoda Shoal. According to the Philippine Navy, there are 17 Chinese military vessels and 28 China Coast Guard (CCG) boats spotted inside the country’s exclusive economic zone (EEZ) between Sept. 23 and 30, or one vessel more than in the previous week Sept.17-23. Five of the warships were seen roaming around the vicinity of Escoda Shoal, along with 10 CCG vessels and 12 maritime militia vessels (MMVs). There are also two PLAN ships in Ayungin Shoal as well as 10 CCG boats and 12...
Read more

Social media seen as cause of rising intermarriages --- Helen Flores - The Philippine Star

MANILA, Philippines — The Commission on Filipinos Overseas (CFO) sees social media as the main reason for the rising number of Filipinos marrying or becoming partners of foreign nationals. In 2022, the CFO recorded 6,854 marriages or partnerships with foreign nationals, a 40.1 percent increase from the 4,891 “intermarriages” recorded in 2021. “First of all, what we see in the increase in the marriage rate of Filipinos or Filipinos with foreign partners is because of social media, (that) is number one; matchings; letters, introduction of their friends,” CFO chairperson Romulo Arugay said at the Bagong Pilipinas Ngayon public briefing yesterday. Arugay said the agency has been registering a high number of intermarriages since 2007, but the figures went down during the COVID-19 pandemic. From over 6,500 Filipinos who married foreign nationals, only 600 are men, he said. Most of them are married to Americans, Japanese, Germans, Canadians and Australians, Arugay said. Arugay warned Fi...
Read more